ClinicalTrials.gg
Sign In

Drug

Insulin efsitora alfa clinical trials

Also written LY3209590.

studies test it
19
open now
0
in phase 3
5
first study started
2016

How studies write it

Studies that test it under each name

Name

Insulin Efsitora Alfa
5
LY3209590 and Basal Insulin-FC
5

Development codes

LY3209590
12

Studies by the year they started

19 studies that test it; most in 2022 (6)

Studies that test insulin efsitora alfa, by start year
YearStudies
20161
20183
20203
20212
20226
20233
20241

By phase

A phase 1/2 study counts in both.

Phase 1
11
Phase 2
3
Phase 3
5

What it is tested for

Each study’s main condition, where its own words name it.

Diabetes Mellitus, Type 2
14
Diabetes Mellitus, Type 1
2

Who runs them

Industry 19 · Other 0

Eli Lilly and Company (19)

Often tested with

Tested in the same studies.

Insulin Glargine (1)

Studies

Open first, then newest update. How each study uses insulin efsitora alfa is read from its arms, and is right about nine times in ten.

Testing it · 19

Codes

What other systems call insulin efsitora alfa · ClinicalTrials.gg INT017512

  • UNII (FDA) OZ465SMQ28INSULIN EFSITORA ALFAOne source FDA
  • NCI Thesaurus C174820Insulin Efsitora AlfaOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.